Post-Acute COVID-19 Syndrome and its association with viral load in HIV patients
DOI:
https://doi.org/10.47464/MetroCiencia/vol33/2/2025/29-35Keywords:
post-acute COVID-19 syndrome, HIV, viral load, CD4 lymphocyte count, risk factorsAbstract
Introduction: The post-acute COVID-19 syndrome refers to the persistence of symptoms after three weeks of infection. Materials and Methods: A cross-sectional study was conducted that included 82 HIV patients, with a confirmed diagnosis of COVID-19, who consulted after three weeks of the illness. The data were analyzed using simple and logistic linear regression with Epidat 4.2 in order to evaluate the association with a viral load >20 copies. Results: 87.2% of the patients were male and 12.8% were female. The median age was 38 years (IQR: 28-55), within an age range of 18 to 69 years. The median time from diagnosis to outpatient consultation was 58 days (IQR 33-67). 48.8% of the patients had mild COVID-19, 34.2% moderate, and 17.1% severe cases. The symptom that persisted most frequently was fatigue at 34.15%, followed by anxiety at 19.51%, cough at 18.29%, and insomnia at 17.07%. The prevalence of post-acute COVID-19 syndrome was 46.3% (95% CI: 42.8-64.4). Conclusions: No relationship was found between having a viral load greater than 20 copies and developing the syndrome; however, a CD4 count below 200 is indeed a risk factor for presenting with post-acute COVID-19 syndrome.
Downloads
References
Prieto MA, Prieto O, Castro HM. Covid prolongado: estudio de corte transversal [Long covid: cross sectional study]. Rev Fac Cien Med Univ Nac Cordoba. 2021 Mar 17;78(1):33-36. Spanish. https://doi.org/10.31053/1853.0605.v78.n1.32048 .
Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, et al. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection. AIDS [Internet]. 2022 Jul 18;36(12):F7–16. https://doi.org/10.1097/qad.0000000000003338
Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clinical Infectious Diseases [Internet]. 2021 Jul 1;74(7):1191–8. https://doi.org/10.1093/cid/ciab611
Stephanie MRL, Leonardo CSR. Síntomas residuales posterior a la infección COVID-19 en un grupo pacientes de la ciudad de Bogotá durante el año 2020, análisis de una cohorte. repository.urosario.edu.co [Internet]. 2021 Aug 23.https://doi.org/10.48713/10336_32332
Fernández-de-las-Peñas C, Gómez-Mayordomo V, Cuadrado ML, et al. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study. Cephalalgia.2021;41(13):1332-1341 https://doi.org/10.1177/03331024211020404
Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C. et al. Más de 50 efectos a largo plazo de la COVID-19: una revisión sistemática y un metanálisis. Sci Rep, 202; 11:16144. https://doi.org/10.1038/s41598-021-95565-8
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nature Medicine [Internet]. 2021 Mar 22;27(4):601–15. https://doi.org/10.1038/s41591-021-01283-z
Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V. Long‐coronavirus disease among people living with HIV in western India: An observational study. Immunity Inflammation and Disease [Internet]. 2021 Jun 2;9(3):1037–43. Available from: https://doi.org/10.1002/iid3.467
Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell [Internet]. 2022 Jan 25;185(5):881-895.e20. https://doi.org/10.1016/j.cell.2022.01.014
Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. The Lancet HIV [Internet]. 2020 May 28;7(8):e554–64. https://doi.org/10.1016/s2352-3018(20)30164-8
Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect [Internet]. 2020 Sep 23;27(1):89–95. https://doi.org/10.1016/j.cmi.2020.09.023
Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, Obeidat M, Obeidat Y, Gerberi D, Taha RM, Kashour Z, Kashour T, Berbari EF, Alkattan K, Tleyjeh IM. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022 May;28(5):657-666. https://doi.org/10.1016/j.cmi.2022.01.014 .
Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho SM. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022 Mar 15;434:120162. https://doi.org/10.1016/j.jns.2022.120162
Abel KM, Carr MJ, Ashcroft DM, Chalder T, Chew-Graham CA, Hope H, Kapur N, McManus S, Steeg S, Webb RT, Pierce M. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients. JAMA Netw Open. 2021 Nov 1;4(11):e2134803. https://doi.org/10.1001/jamanetworkopen.2021.34803
Luo D, Mei B, Wang P, Li X, Chen X, Wei G, Kuang F, Li B, Su S. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis. Clin Microbiol Infect. 2024 Mar;30(3):328-335. https://doi.org/10.1016/j.cmi.2023.10.016 .
Downloads
Published
Issue
Section
License
Copyright (c) 2025 John Jaime Zapata Feria, Luis Carlos Avellaneda Curcho, Mónica Liseth Holguín Barrera, Lorena García Agudelo

This work is licensed under a Creative Commons Attribution 4.0 International License.


